Abstract

BACE1 (beta-site amyloid precursor protein-cleaving enzyme 1) is a membrane-tethered member of the aspartyl proteases, essential for the production of beta-amyloid, a toxic peptide that accumulates in the brain of subjects affected by Alzheimer disease. The BACE1 C-terminal fragment contains a DXXLL motif that has been shown to bind the VHS (VPS27, Hrs, and STAM) domain of GGA1-3 (Golgi-localized gamma-ear-containing ARF-binding proteins). GGAs are trafficking molecules involved in the transport of proteins containing the DXXLL signal from the Golgi complex to endosomes. Moreover, GGAs bind ubiquitin and traffic synthetic and endosomal ubiquitinated cargoes to lysosomes. We have previously shown that depletion of GGA3 results in increased BACE1 levels and activity because of impaired lysosomal degradation. Here, we report that the accumulation of BACE1 is rescued by the ectopic expression of GGA3 in H4 neuroglioma cells depleted of GGA3. Accordingly, the overexpression of GGA3 reduces the levels of BACE1 and beta-amyloid. We then established that mutations in the GGA3 VPS27, Hrs, and STAM domain (N91A) or in BACE1 di-leucine motif (L499A/L500A), able to abrogate their binding, did not affect the ability of ectopically expressed GGA3 to rescue BACE1 accumulation in cells depleted of GGA3. Instead, we found that BACE1 is ubiquitinated at lysine 501 and is mainly monoubiquitinated and Lys-63-linked polyubiquitinated. Finally, a GGA3 mutant with reduced ability to bind ubiquitin (GGA3L276A) was unable to regulate BACE1 levels both in rescue and overexpression experiments. These findings indicate that levels of GGA3 tightly and inversely regulate BACE1 levels via interaction with ubiquitin sorting machinery.

Highlights

  • Alzheimer disease (AD)3 is a devastating neurodegenerative disorder that results in loss of memory and cognitive function, Grants 1R01AG025952-04 and 1R01AG033016-01A1

  • A GGA3 mutant with reduced ability to bind ubiquitin (GGA3L276A) was unable to regulate BACE1 levels both in rescue and overexpression experiments. These findings indicate that levels of GGA3 tightly and inversely regulate BACE1 levels via interaction with ubiquitin sorting machinery

  • We have shown that depletion of GGA3 enhances ␤-secretase activity as evidenced by increased levels of the amyloid precursor protein (APP) C-terminal fragment of 99 amino acids and A␤

Read more

Summary

EXPERIMENTAL PROCEDURES

Antibodies and Expression Vectors—Anti-HA and anti-Myc (mono- and polyclonal) antibodies were purchased from Cell Signaling, Danvers, MA. Equal amounts (30 ␮g) of each sample were separated by SDS-PAGE using 4 –12% BisTris gels (Invitrogen), and WB analysis was performed using antiMyc or anti-HA antibody to detect BACE1 or GGA3, respectively, as described previously [34]. The following day, the cells were cotransfected with 3 ␮g of BACE1-V5 or BACE1-V5 K501R and 3 ␮g of HAubiquitin using Superfect transfection reagent (Qiagen, Valencia, CA) In another set of experiments, H4-APP751 cells were cotransfected with 3 ␮g of BACE1-V5 and Ub WT or mutant expression vectors. BACE1 accumulation was rescued by the expression of RNAi-resistant GGA3 mutant in H4-shGGA3 cells (vector versus HA-GGA3RNAiRes unpaired t test with Welch correction **, p ϭ 0.001). Unpaired t test with Welch correction was employed for data sets that passed normality test but had different standard deviations

RESULTS
DISCUSSION
AA AA
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call